Professor Paolo Sportoletti, MD, PhD is a translational hematologist with a strong expertise and track record in the field of lymphoid and myeloid hematological malignancies. He completed his education training under the supervision of Prof. Falini a widely-recognized expert in the field of lymphomas and leukemias. He was a postdoctoral fellow at the Memorial Sloan Kettering Cancer Center (New York) and BIDMC/Harvard Medical School (Boston), in leading laboratories of cancer research worldwide. He is an Associate Professor and Consultant at the Hematology Section at the University of Perugia, a national reference center for patients suffering from Myeloid and Lymphoid malignancies. Prof. Sportoletti has a broad background and track record in the field blood cancer that is documented by the publication of 99 peer reviewed papers. His research encompasses basic research and pre-clinical models to study the role of genetic mutations in Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML). He made the seminal discovery of NOTCH1 mutation as an adverse prognostic factor in CLL and contributed to important work on NPM1 and BCOR mutations in AML.